secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0000950170-25-041749
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo announces 1-for-12 reverse stock split effective March 20, 2025 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- 1-for-12 reverse stock split effective 5:00 p.m. ET on March 20, 2025; adjusted trading begins March 21.
- Outstanding shares reduce from ~21.4M to ~1.8M; fractional shares paid in cash at March 19 closing price.
- Approved by shareholders on Nov 20, 2024; board selected 1-for-12 ratio on March 6, 2025.
- Intended to regain compliance with Nasdaq $1.00 minimum bid price for continued listing on Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025041749/0000950170-25-041749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025041749/onvo-20250319.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-041749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer